The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

BACKGROUND: There have been few treatment advances for patients with glioblastoma (GBM) despite increasing scientific understanding of the disease. While factors such as intrinsic tumor biology and drug delivery are challenges to developing efficacious therapies, it is unclear whether the current cl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Vanderbeek, Alyssa M, Rahman, Rifaquat, Fell, Geoffrey, Ventz, Steffen, Chen, Tianqi, Redd, Robert, Parmigiani, Giovanni, Cloughesy, Timothy F, Wen, Patrick Y, Trippa, Lorenzo, Alexander, Brian M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Meta-Analyses
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280141/
https://ncbi.nlm.nih.gov/pubmed/29518210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy027
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak